Jeff Yass’s Neuphoria Therapeutics NEUP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.4K Buy
+14,732
New +$54.8K ﹤0.01% 12869
2024
Q4
– Sell
-2,845
Closed -$14.9K – 13470
2024
Q3
$14.9K Buy
+2,845
New +$22.5K ﹤0.01% 11675

Other funds holding NEUP

Jeff Yass's NEUP Position: Q3 2026 in Review

Jeff Yass opened a new position in Neuphoria Therapeutics (NEUP) in Q3 2026: 14,732 shares worth $52.4K. The stake represents ﹤0.01% of the portfolio and ranks #12869 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NEUP as recently as Q3 2024.

Jeff Yass first reported a position in NEUP in Q3 2024 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold NEUP as of Q3 2026.

  • Jeff Yass held 14,732 shares of Neuphoria Therapeutics worth $52.4K as of Q3 2026.
  • Neuphoria Therapeutics was a new Jeff Yass position in Q3 2026.
  • Neuphoria Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12869 holding.
  • Jeff Yass first reported a position in Neuphoria Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.